End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,495 KRW | -0.43% | +20.73% | -19.10% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
Sales 2018 | - | Sales 2019 | - | Capitalization | 72.04M 98.17B 6.01B |
---|---|---|---|---|---|
Net income 2018 | 3M 4.09B 250M | Net income 2019 | 23M 31.34B 1.92B | EV / Sales 2018 * | - |
Net cash position 2018 * | - 0 0 | Net cash position 2019 * | - 0 0 | EV / Sales 2019 * | - |
P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 87.57% |
1 day | -0.43% | ||
1 week | +20.73% | ||
Current month | -7.66% | ||
1 month | +12.92% | ||
3 months | -18.63% | ||
6 months | +7.87% | ||
Current year | -19.10% |
Managers | Title | Age | Since |
---|---|---|---|
Ki-Sub Lee
CEO | Chief Executive Officer | 73 | 15/07/15 |
Jae-Moon Lee
PSD | President | 66 | - |
In-Chul Kim
PRN | Corporate Officer/Principal | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ki-Sub Lee
CEO | Chief Executive Officer | 73 | 15/07/15 |
Jae-Moon Lee
PSD | President | 66 | - |
1st Jan change | Capi. | |
---|---|---|
-19.10% | 72.04M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- A284620 Stock